Natco Pharma Share Price
28 Oct, 2026 3:57 PM (IST)
Natco Pharma Performance
- Today's Low
- ₹779
- Today's High
- ₹802
- 52 Week Low
- ₹774
- 52 Week High
- ₹1,217
- Open Price₹785
- Previous Close₹795
- Volume950,456
- 50 DMA₹826.70
- 100 DMA₹865.10
- 200 DMA₹897.80
Natco Pharma Chart
Investment Returns
- Over 1 Month -4.74%
- Over 3 Month -13.76%
- Over 6 Month -26.64%
- Over 1 Year -3.1%
Smart Investing Starts Here Start SIP with Natco Pharma for Steady Growth!
Natco Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 13.6
- PEG Ratio
- -0.4
- Market Cap Cr
- 15,556
- P/B Ratio
- 1.5
- Average True Range
- 18.5
- EPS
- 58.3
- Dividend Yield
- 0.6
- MACD Signal
- -10.4
- RSI
- 43.17
- MFI
- 46.9
Latest Stock News Updates
Outcome of the Fund-raising Committee meeting approving the allotment of 17058082 Equity shares
- BSE India
- 5 days 9 hours ago
Update on Trading Window Closure period
- BSE India
- 6 days 12 hours ago
Intimation of closure of the Issue period of the Rights Issue of NATCO Pharma Limited (the "Company")
- BSE India
- 6 days 17 hours ago
Natco Pharma Financials
Natco Pharma Technicals
EMA & SMA
- Bearish Moving Average 12
- Bullish Moving Average 4
- 20 Day
- ₹799.20
- 50 Day
- ₹826.70
- 100 Day
- ₹865.10
- 200 Day
- ₹897.80
Resistance and Support
- R3 826.60
- R2 814.30
- R1 803.60
- S1 780.70
- S2 768.40
- S3 757.80
Natco Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-09-25 | Rights issue of Equity Shares | |
| 2026-09-09 | Fund Raising | |
| 2026-08-14 | Quarterly Results & Interim Dividend | |
| 2026-05-29 | Audited Results | |
| 2026-03-24 | Scheme of Arrangement | Inter alia, to consider among other things, the Scheme of Arrangement for the demerger of Agrochemicals Division on a going concern basis into its WoS i.e., Natco Crop Health Sciences Limited. |
About Natco Pharma
Natco Pharma Ltd. is leading pharmaceutical company in India, specializing in production of generic medicines, bulk drugs, & specialty pharmaceuticals. Founded in 1981, Natco has established itself as key player in global pharmaceutical industry, with strong focus on oncology, cardiology, & gastroenterology segments. company operates state of the art manufacturing facilities that comply with global regulatory standards, ensuring production of high quality medicines. Natco Pharma is known for its innovation, particularly in development of affordable generic versions of high cost drugs, which has made it preferred partner for healthcare providers worldwide.
NATCO Pharma Limited (NATCO) is pharmaceutical firm that focuses on research & development & is vertically integrated. Its core competencies include creating, producing, & selling complicated pharmaceuticals for specific therapeutic areas. NATCO is now present in three business categories of contract manufacturing business, active pharmaceutical ingredients (APIs), & final dosage formulations (FDF).
- NSE Symbol
- NATCOPHARM
- BSE Symbol
- 524816
- ISIN
- INE987B01026
Similar Stocks to Natco Pharma
Popular Stocks
Natco Pharma FAQs
Natco Pharma share price is ₹793 As on 29 October, 2026 | 06:25
The Market Cap of Natco Pharma is ₹15556.1 Cr As on 29 October, 2026 | 06:25
The P/E ratio of Natco Pharma is 13.6 As on 29 October, 2026 | 06:25
The PB ratio of Natco Pharma is 1.5 As on 29 October, 2026 | 06:25
The 52 week High & Low of Natco Pharma is ₹1216.8/₹773.6 respectively As on 29 October, 2026 | 06:25
Evaluate company's performance in pharmaceutical industry & its product pipeline before investing
Key metrics include revenue growth, product approvals, & profit margins.
Open Demat account with 5 Paisa Capital & post doing KYC & active account search for Natco Pharma share, you can then put order as you prefer.
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.